Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atomic bomb and leukemia.

M Ichimaru1, M Tomonaga, T Amenomori

  • 1Department of Hematology, Nagasaki University School of Medicine, Japan.

Journal of Radiation Research
|December 1, 1991
PubMed
Summary

Atomic bomb radiation exposure significantly increased chronic myeloid leukemia (CML) risk in Hiroshima survivors, with a likely threshold between 0.09-0.5 Gy. Acute leukemia thresholds were higher, and chromosome aberrations were observed in survivors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioconversion studies in cultured cells of Corydalis species.

Die Pharmazie·2004
Same author

Cassipoureamide-A and -B: new sulfur-containing amides from stem wood of Cassipourea guianensis.

Journal of natural products·2001
Same author

Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group.

Japanese journal of clinical oncology·2000
Same author

Cardiotonic activity of the rhizome of Polygonatum sibiricum in rats.

Biological & pharmaceutical bulletin·1998
Same author

Hypoglycemic activity of some triterpenoid glycosides.

Journal of natural products·1997
Same author

Hypoglycemic effect of the rhizomes of Polygala senega in normal and diabetic mice and its main component, the triterpenoid glycoside senegin-II.

Planta medica·1996

Area of Science:

  • Radiation epidemiology
  • Hematology
  • Atomic bomb survivor studies

Background:

  • Leukemia is a significant health concern for atomic bomb survivors.
  • Understanding radiation-induced leukemia is crucial for public health.
  • Previous dosimetry systems (T65D) have limitations.

Purpose of the Study:

  • To characterize leukemia in atomic bomb survivors using updated dosimetry (DS86).
  • To determine radiation dose thresholds for specific leukemia types.
  • To investigate atypical leukemia and myeloproliferative diseases post-exposure.

Main Methods:

  • Analysis of leukemia incidence in atomic bomb survivors.
  • Utilizing the DS86 dosimetry system for dose estimation.
  • Chromosome aberration analysis in hematopoietic stem cells and T-cells.

Main Results:

  • Chronic myeloid leukemia (CML) showed the highest ratio among leukemias in Hiroshima survivors.
  • The CML occurrence threshold was estimated between 0.09-0.5 Gy, while acute leukemia threshold was near 1 Gy.
  • No M3 acute myeloid leukemia (AML) cases were observed at doses ≥1 Gy, but atypical AML cases were noted.
  • Aplastic anemia incidence did not increase, but atypical myeloproliferative diseases were observed.
  • Chromosome aberrations were consistent between colony-forming cells and peripheral T-cells in survivors.

Conclusions:

  • CML is a characteristic leukemia associated with atomic bomb radiation exposure.
  • Radiation dose thresholds vary significantly between leukemia subtypes.
  • Chromosome studies reveal persistent aberrations in exposed individuals, indicating long-term biological effects.

Related Experiment Videos